We are live on ! Find out more
BDTX icon

Black Diamond Therapeutics
BDTX

87 hedge funds and large institutions have $103M invested in Black Diamond Therapeutics in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 16

1.56% less ownership

Funds ownership: 86.21% → 84.65% (-1.6%)

9% less funds holding

Funds holding: 96 → 87 (-9)

29% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 28

52% less capital invested

Capital invested by funds: $212M → $103M (-$109M)

77% less call options, than puts

Call options by funds: $38K | Put options by funds: $165K

Holders
87
Holders Change
-9
Holders Change %
-9.38%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
35
Reduced
16
Closed
28
Calls
$38K
Puts
$165K
Net Calls
-$127K
Net Calls Change
+$2.44M

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$2.01M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.86M
3
VPC
Vestal Point Capital
New York
+$1.64M
4
AAA
Affinity Asset Advisors
New York
+$1.6M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
ECM
ExodusPoint Capital Management
New York
-$3.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.03M
3
OCA
Octagon Capital Advisors
New York
-$2.58M
4
DCM
Driehaus Capital Management
Illinois
-$2.41M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$22.4M -$767K -267,668 -2%
BG
2
Bellevue Group
Switzerland
$18.2M – – –
VPC
3
Vestal Point Capital
New York
$12M +$1.64M +571,500 +11%
NMC
4
NEA Management Company
Maryland
$9.52M – – –
BlackRock
5
BlackRock
New York
$7.53M +$61.3K +21,379 +0.6%
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.17M +$275K +95,930 +4%
TCM
7
Tang Capital Management
California
$4.43M +$2.01M +700,000 +51%
SL
8
Siren LLC
Connecticut
$2.24M – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$2.05M +$41.4K +14,439 +2%
Renaissance Technologies
10
Renaissance Technologies
New York
$1.93M +$1.86M +650,200 +256%
State Street
11
State Street
Massachusetts
$1.89M +$213K +74,245 +9%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$1.42M +$1.16M +405,579 +159%
AAA
13
Affinity Asset Advisors
New York
$1.2M +$1.6M +559,163 New
Millennium Management
14
Millennium Management
New York
$1.19M +$950K +331,331 +146%
BCM
15
Boxer Capital Management
California
$1.08M +$1.45M +506,000 New
Goldman Sachs
16
Goldman Sachs
New York
$1.04M +$581K +202,820 +72%
KCM
17
Kennedy Capital Management
Missouri
$928K -$640K -223,243 -34%
Northern Trust
18
Northern Trust
Illinois
$819K +$108K +37,633 +11%
Connor, Clark & Lunn Investment Management (CC&L)
19
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$528K -$107K -37,472 -13%
Wellington Management Group
20
Wellington Management Group
Massachusetts
$473K +$46.7K +16,279 +8%
Morgan Stanley
21
Morgan Stanley
New York
$467K +$267K +93,016 +74%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$443K +$187K +65,341 +46%
N
23
Nuveen
North Carolina
$431K +$65.3K +22,802 +13%
Fidelity Investments
24
Fidelity Investments
Massachusetts
$420K +$48.9K +17,059 +10%
Stifel Financial
25
Stifel Financial
Missouri
$355K +$44.9K +15,676 +10%
1
2 3 4 5

BDTX Hedge Fund Activity: Q4 2024 in Review

87 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Black Diamond Therapeutics (BDTX) for Q4 2024, worth a combined $103M — down 52% from $212M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of BDTX and 20 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 35 added.

The largest buyer was Tang Capital Management, adding an estimated $2.01M. The largest seller was ExodusPoint Capital Management, exiting entirely with an estimated $3.8M sold.

  • 87 institutional investors held Black Diamond Therapeutics (BDTX) as of Q4 2024, down from 96 in Q3 2024.
  • Funds reported $103M of Black Diamond Therapeutics stock for Q4 2024, down 52% quarter-over-quarter.
  • 20 funds opened new Black Diamond Therapeutics positions in Q4 2024 and 28 closed out, a net change of -8 holders.
  • The largest Black Diamond Therapeutics buyer in Q4 2024 was Tang Capital Management, an estimated $2.01M added.
  • The largest Black Diamond Therapeutics seller in Q4 2024 was ExodusPoint Capital Management, an estimated $3.8M sold.

Based on aggregated 13F filings for Q4 2024.